These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 1348720)
21. Assessment of proliferating cell nuclear antigen (PCNA) in breast cancer using anti-PCNA PC10 and 19A2: correlation with 5-bromo-2'-deoxyuridine or tritiated thymidine labeling and flow cytometric analysis. He W; Meyer JS; Scrivner DL; Koehm S; Hughes J Biotech Histochem; 1994 Jul; 69(4):203-12. PubMed ID: 7918835 [TBL] [Abstract][Full Text] [Related]
22. [Immunohistochemical study of proliferating cell nuclear antigen (PCNA) in gynecological tumors and their related lesions]. Sawada M; Ueda G; Inoue M; Shimizu H; Ogawa H; Nakazawa A; Fujita M; Tanizawa O; Tsujimoto M Nihon Sanka Fujinka Gakkai Zasshi; 1992 Feb; 44(2):181-7. PubMed ID: 1347557 [TBL] [Abstract][Full Text] [Related]
23. Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: comparison with tumour grade, mitotic index, and silver-staining nucleolar organizer region numbers. Delahunt B; Bethwaite PB; Nacey JN; Ribas JL J Pathol; 1993 Aug; 170(4):471-7. PubMed ID: 8105046 [TBL] [Abstract][Full Text] [Related]
24. Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/Cyclin 19A2. Correlation with Ki-67 labeling. Kamel OW; LeBrun DP; Davis RE; Berry GJ; Warnke RA Am J Pathol; 1991 Jun; 138(6):1471-7. PubMed ID: 1675840 [TBL] [Abstract][Full Text] [Related]
25. Proliferating cell nuclear antigen counts in formalin-fixed paraffin-embedded tissue correlate with Ki-67 in fresh tissue. Dervan PA; Magee HM; Buckley C; Carney DN Am J Clin Pathol; 1992 May; 97(5 Suppl 1):S21-8. PubMed ID: 1349455 [TBL] [Abstract][Full Text] [Related]
26. Immunostaining for proliferating cell nuclear antigen: its role in determination of proliferation in routinely processed human brain tumor specimens. Khoshyomn S; Maier H; Morimura T; Kitz K; Budka H Acta Neuropathol; 1993; 86(6):582-9. PubMed ID: 7906072 [TBL] [Abstract][Full Text] [Related]
28. Tissue fixation for immunohistochemical detection of proliferating cell nuclear antigen with PC10 monoclonal antibody. Casasco A; Casasco M; Cornaglia AI; Danova M; Giordano M; Calligaro A Biotech Histochem; 1994 Mar; 69(2):112-7. PubMed ID: 7911337 [TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical expression of proliferating cell nuclear antigen (PCNA) in intracranial glioma and meningioma. Shih YH; Kadota Y; Sato K; Sueyoshi N; Shirai T Zhonghua Yi Xue Za Zhi (Taipei); 1994 Apr; 53(4):193-7. PubMed ID: 7911730 [TBL] [Abstract][Full Text] [Related]
30. Estimation of tumor growth fractions in archival formalin-fixed, paraffin-embedded tissues using two anti-PCNA/Cyclin monoclonal antibodies. Factors affecting reactivity. Gelb AB; Kamel OW; LeBrun DP; Warnke RA Am J Pathol; 1992 Dec; 141(6):1453-8. PubMed ID: 1281622 [TBL] [Abstract][Full Text] [Related]
31. [Analysis of proliferating cell nuclear antigen (PCNA) expression in 24 cases of primary non-small cell pulmonary carcinomas and correlation with survival]. Castellano VM; Sotelo T; Ballestín C; López-Encuentra A; Varela G Arch Bronconeumol; 1996 Mar; 32(3):127-31. PubMed ID: 8634790 [TBL] [Abstract][Full Text] [Related]
32. [Study of proliferating cell nuclear antigen (PCNA), nucleolar organizer regions (NORs) and mitotic activity in epithelial ovarian tumors]. Yamanaka S; Nagai N; Ohama K Nihon Sanka Fujinka Gakkai Zasshi; 1993 Mar; 45(3):234-40. PubMed ID: 8098347 [TBL] [Abstract][Full Text] [Related]
33. Proliferating cell nuclear antigen (PCNA) in atypical and malignant meningiomas. Zimmer C; Gottschalk J; Cervos-Navarro J; Martin H; Beil M; Jautzke G Pathol Res Pract; 1992 Dec; 188(8):951-8. PubMed ID: 1363764 [TBL] [Abstract][Full Text] [Related]
34. Cyclin/PCNA immunostaining as an alternative to tritiated thymidine pulse labelling for marking S phase cells in paraffin sections from animal and human tissues. Galand P; Degraef C Cell Tissue Kinet; 1989 Sep; 22(5):383-92. PubMed ID: 2575456 [TBL] [Abstract][Full Text] [Related]
35. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. Hall PA; Levison DA; Woods AL; Yu CC; Kellock DB; Watkins JA; Barnes DM; Gillett CE; Camplejohn R; Dover R J Pathol; 1990 Dec; 162(4):285-94. PubMed ID: 1981239 [TBL] [Abstract][Full Text] [Related]
36. Proliferating cell nuclear antigen labeling index of preoperative biopsy specimens in gastric carcinoma with special reference to prognosis. Maeda K; Chung YS; Onoda N; Kato Y; Nitta A; Arimoto Y; Yamada N; Kondo Y; Sowa M Cancer; 1994 Feb; 73(3):528-33. PubMed ID: 7905361 [TBL] [Abstract][Full Text] [Related]
37. Proliferating cell nuclear antigen and Ki-67 in lung carcinoma. Correlation with DNA flow cytometric analysis. Kawai T; Suzuki M; Kono S; Shinomiya N; Rokutanda M; Takagi K; Ogata T; Tamai S Cancer; 1994 Nov; 74(9):2468-75. PubMed ID: 7923002 [TBL] [Abstract][Full Text] [Related]
38. PCNA immunopositivity index as a substitute to 3H-thymidine pulse-labeling index (TLI) in methanol-fixed human lymphocytes. Galand P; Del Bino G; Morret M; Capel P; Degraef C; Fokan D; Feremans W Leukemia; 1995 Jun; 9(6):1075-84. PubMed ID: 7596173 [TBL] [Abstract][Full Text] [Related]
39. Comparative analysis of proliferating cell nuclear antigen, bromodeoxyuridine, and mitotic index in uveal melanoma. Ghazvini S; Kroll S; Char DH; Frigillana H Invest Ophthalmol Vis Sci; 1995 Dec; 36(13):2762-7. PubMed ID: 7499099 [TBL] [Abstract][Full Text] [Related]
40. Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer. Ebina M; Steinberg SM; Mulshine JL; Linnoila RI Cancer Res; 1994 May; 54(9):2496-503. PubMed ID: 7909277 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]